NEW YORK, Feb. 7 (GenomeWeb News) - The Virginia Bioinformatics Institute at Virginia Tech and Orion Integrated Biosciences plan to co-develop new diagnostic methods for viral pathogens, the partners said today.
Under the agreement, VBI will integrate data on encephalic and hemorrhagic viruses from its PathPort project into Orion's integrated computational analysis system.
"The lack of diagnostic tools that can integrate and analyze molecular surveillance data is a major gap in disease prevention and the development of countermeasure responses," said Oswald Crasta, director of bioinformatics for VBI's cyberinfrastructure group.
Financial details of the deal were not provided.
VBI 's PathPort platform includes pathogens with the potential use as biological weapons, according to the statement.
New York-based Orion Integrated Biosciences is a drug-discovery and viral disease detection shop, focusing on the development of antiviral agents and devices that can recognize lethal pathogens in medical and military settings.